Johnson & Johnson

JNJ
HealthcareDividend Aristocrat
$229.23
2.27%Overvalued

Johnson & Johnson (JNJ) is a Healthcare company that currently yields 2.27% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $153.72 and the overvaluation threshold at $209.36. Johnson & Johnson holds a quality score of 44/100 (Average), reflecting 9 consecutive years of dividend growth with a 60% payout ratio. The 5-year dividend CAGR stands at 5.2%.

JNJ Dividend Yield History — Weiss Valuation

Underval. $153.72Overval. $209.36
Price
Undervalued band
Overvalued band

Why Now?

Johnson & Johnson is trading near its historical overvaluation band.

Current yield 2.3% vs historical max 3.4% (67% of maximum).

9 years of uninterrupted dividends.

Reasonable payout ratio of 60%.

JNJ Dividend Income Projection — DRIP Compounder

Dividend Compounder (DRIP)

$

Year 1 Income

$239

Year 10 Income

$489

Yield on Cost

5.08%

Total Income

$3,477

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

JNJ Dividend Quality Score

Quality Score

44/ 100

Average

Payout Ratio12/25
Dividend Streak12/25
Growth (CAGR 5Y)15/20
Yield vs History5/15
FCF Coverage0/15

Key Metrics

Current Price$229.23
Annual Dividend$5.20
Current Yield2.27%
Yield — Max (10Y)3.38%
Yield — Min (10Y)2.48%
Undervalued Below$153.72
Overvalued Above$209.36
Payout Ratio60.25%
CAGR Dividend 5Y5.2%
CAGR Dividend 10Y—
Years No Cut9y
9
consecutive years of dividend growth

In-depth analysis

→ JNJ Dividend Analysis Article

Collections

→ Dividend Aristocrats→ Full Watchlist